Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...

Patients suffering from myocardial infarction who receive early add-on lipid-lowering medication have a significantly better ...

Patients suffering from myocardial infarction who receive early add-on lipid-lowering medication have a significantly better prognosis than those who ...

Early ezetimibe initiation after myocardial infarction significantly lowers cardiovascular events compared to delayed or no combination lipid-lowering therapy.

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute event.

Giving patients a combination of drugs earlier in their treatment could prevent thousands of heart attacks, according to a ...

Analysis suggests that treating heart attack patients earlier with a combination of statins and the cholesterol-lowering drug ezetimibe could prevent thousands of new heart attacks over a decade.

Adding ezetimibe (Zetia) therapy to statins early after a heart attack improved outcomes, Swedish national records suggested.

Treating patients earlier with a combination of statins and the cholesterol-lowering drug ezetimibe could prevent thousands of new heart attacks, strokes, and death over a decade, according to ...

Thousands of heart attacks could be prevented if the NHS prescribed a "low-cost" drug combination, according to new research. A study conducted by an international team of scientists suggests that ...